New York Stock Exchange (NYSE) · Industrials
Resideo Technologies, Inc. REZI
SpeculativeScore band: 40–50
The thesis, in one sentence
A reanalysis after this company's spin-off found that all three triggered red flags were measuring the pre-spin entity, not the remaining business, whose pricing-power moat is actually intact, but it also uncovered a real new problem: cash flow from operations badly lagged reported net profit.
Written for this site in plain English, without figures. The arithmetic is in the full report.
Key risks
- Cash flow from operations is badly lagging reported net profit
- Replacement demand is assumed to be defensive, which may not hold
- Segment restructuring charges have jumped sharply since the spin-off
What would change the verdict
- Operating margin falls for two consecutive quarters
- Net debt relative to EBITDA rises into deeply levered territory
- Return on equity falls to a very low level
- Days sales outstanding rise for two consecutive quarters
Read it yourself
Step five of the method is the reader's: open the latest annual or quarterly report and read it before acting on anything here. A score is a summary, and a summary is not understanding.
Next report expected 2026-11-05. The deep report was written against the filings available on 2026-09-18; anything published since is not in it.
Price, one year
DCF valuation range
range of the DCF modelsbase casetoday's price
Valuation range, shape only. Figures in the full version.
Monte Carlo outcome shape
scenarios below today's pricescenarios above today's pricetoday's price
Distribution of simulated outcomes around today's price. Bar heights only; the scale and the percentiles are in the full version.
Where the money goes
Last four reported quarters, 2025-09 → 2026-06, in USD. Filings data as gathered on 2026-09-18. Figures rounded to three significant digits.
Chapter one: Executive summary (1 page: thesis, estimated value, verdict)
TRACKER;2026-09-18;REZI;…;…;4/10;5/10;4.5/10;5/9;SPECULATIV;…%;60
REZI — Resideo Technologies, Inc. · deep-value reanalysis after the thesis broke
September 18, 2026 · price … · common market cap … · NYSE · Industrials / Building Products Reanalysis mechanically triggered: 3 of 7 falsifiers of the 2026-09-03 thesis triggered on 2026-09-17.
Executive summary (1 page: thesis, estimated value, verdict)
On 2026-09-17 the thesis checker reported three falsifiers broken out of seven: marja_operationala
(operating margin), datorie_neta_ebitda (net debt/EBITDA), and marja_bruta (gross margin). This resumption's task is to say whether the assumption that supported
the verdict still holds. The answer, verified line by line in the 2026-08-12 10-Q and the FY2025 10-K,
is that none of the three measures the business's deterioration — all three measure a company that
hasn't existed since August 3, 2026 — but that the investigation they triggered found something else, real, that
the 2026-09-03 analysis had missed: the owner-earnings base was ~8% too high, and this moves the verdict
from "fair price, slightly below value" to "fair price, slightly above value."
The autopsy of the three, with figures:
marja_bruta = [0.3004; 0.2882]against the< 0.40threshold. The two quarters are Q2 and Q1 2026, both consolidated with ADI, the distributor that made 64% of revenue at a 22.7% gross margin ((1,286 − 994)/1,286, 10-Q, ADI segment table). The remaining segment — Products and Solutions — had a gross margin of 43.60% in Q2 2026, versus 42.94% in Q2 2025. The falsifier is correctly calibrated for the post-spin entity and cleans itself up at the 2026-11-05 report.marja_operationala = [0.107; 0.0533]against< 0.15. The same contamination, plus one more, in the opposite direction: 0.107 isn't the reported operating margin. Q2 2026 GAAP operating income is … on … of revenue, i.e. 6.61%; yfinance's "EBIT" label adds the … of "Other income, net," of which … is the one-off gain from terminating the Tax Matters Agreement with Honeywell. The falsifier was thus flattered by a one-off item and still broke.datorie_neta_ebitda = 4.6096against> 4.5. The metric is named EBITDA but computes (total debt − cash) / trailing-4-quarter EBIT: (3,622 − 549) / 666 = 4.61. The gross debt of … includes the … of ADIG bonds held in escrow at 2026-07-04, which went to ADIG on 2026-08-03, and doesn't reflect the … repayment made right after. The 4.5 threshold was set by the prior analysis with 2.93× on adjusted EBITDA in mind — a denominator mix-up.
So: transition noise, not structural deterioration. The positive evidence is the remaining segment's series, taken from the 10-K's and 10-Q's CODM tables: P&S gross margin 38.62% (2023) → 40.95% (2024) → 42.08% (2025) → 42.68% (H1 2026), a 406-basis-point expansion over three years, achieved through tariffs, input inflation, and a weak U.S. residential market. Pricing power, which is the whole moat thesis, is intact.
What did deteriorate, and appears in none of the three falsifiers:
- The remaining segment's operating margin fell, from 21.14% (H1 2025) to 18.99% (H1 2026) — 215 basis points. Broken down: restructuring +…, litigation costs +…, R&D +… Without restructuring and litigation, the margin is 21.84% versus 21.22%, i.e. still rising. But segment restructuring ran … → 14 → … in 2023-2025 and … in the first half of 2026 alone, and adjusted EBITDA excludes it entirely.
- Cash conversion broke in H1 2026: CFO of … on net profit of … Adjusted for the one-off … Tax Matters Agreement payment, underlying CFO is … versus 135 in H1 2025. Working capital absorbed … (receivables 149, inventory 45, current liabilities 50) on revenue growing 4.8%.
The owner-earnings base is thus rewritten from 250 to … FCFE (the bridge in the valuation chapter: adjusted EBITDA of … minus restructuring 45, SBC 32, interest 110, tax 95, capex 85, working capital 20). At …, 5% growth, and an 11% cost of equity — below the 12.0% CAPM implied by a beta of 1.566 — the five triangulated models give a range from … to …, with a median of …, and Monte Carlo over 20,000 scenarios gives a median of …, undervaluation probability …%, and only …% chance of a margin of safety above 30%. The 2026-09-03 analysis gave a … median and …% — and this despite the price meanwhile falling from … to …
Verdict: WATCH, no position. Not because the thesis broke — the underlying business is better than any consolidated figure from the last four quarters shows — but because at … there's no margin of safety on assumptions I can defend, and the entire gap to the consensus target of … sits in a single parameter: the multiple. The analyst market pays 12.3× adjusted EBITDA at their target; I'm paying 7.9× today, and an 11% DCF refuses the re-rating. The first real checkpoint is 2026-11-05, the first report where ADI appears as a discontinued operation and where the post-spin balance sheet becomes fact, not estimate.
Figures were removed from this excerpt. The full report opens free for five tickers a week — see what's open now.
Full report contents
- Executive summary (1 page: thesis, estimated value, verdict)
- 🔒 The business and the moat (how it makes money, competitive advantage, durability) (Available in the full report)
- 🔒 Management and capital allocation (track record, buybacks/dividends/acquisitions, skin in the game) (Available in the full report)
- 🔒 What has changed in the last 4 quarters (line-by-line balance sheet from the data pack, margins, cash conversion — explains EVERY large swing) (Available in the full report)
- 🔒 Balance-sheet analysis — Quality of Earnings (Thornton O'Glove method) (Available in the full report)
- 🔒 CEO profile — Outsider traits (William Thorndike method) (Available in the full report)
- 🔒 Accounting red flags (accruals, dilution, one-offs, accounting-policy changes) (Available in the full report)
- 🔒 Triangulated valuation (conservative DCF with explicit assumptions + earnings power value + 5-year historical multiples + Monte Carlo from step 5; a range, not a point) (Available in the full report)
- 🔒 Pre-mortem (why the thesis could be wrong — 3 concrete scenarios) (Available in the full report)
- 🔒 Verdict compared to the tracker's GBL score (convergence/divergence and why) (Available in the full report)
Evaluation history
| Date | Verdict |
|---|---|
| 2026-08-06 | Avoid |
| 2026-09-03 | Speculative |
| 2026-09-06 | Speculative |
| 2026-09-18 | Speculative |
Want the rest of this report?
Subscribe to get one full deep report a week by email, the day before it opens on the site.